Neuroendocrine tumours (NETs) are a group of neoplasms that originate in secretory cells known as neuroendocrine cells, which are distributed throughout the body.1,2 These can be associated with debilitating symptoms and may sometimes severely compromise a patient’s overall health.3
Understand the fundamentals of NETs, exploring the nature of these tumours, their classification and grading and diagnosis and treatment. Using this background knowledge will allow you to further your understanding of gasteroenteropancreatic neuroendocrine tumours (GEP-NETs).
Quick links
GEP, gastroenteropancreatic; NET, neuroendocrine tumour; PRRT, peptide receptor radionuclide therapy; PSMA, prostate-specific membrane antigen.
References
- Canadian Cancer Society. What are neuroendocrine tumours? https://cancer.ca/en/cancer-information/cancer-types/neuroendocrine-tumo... (Accessed: June 2022).
- Kidd M, et al. Cell Mol Gastroenterol Hepatol. 2015;1:131–153.
- Cives M, Strosberg JR. CA Cancer J Clin. 2018;68(6):471–487.